37 Countries to Receive GAVI Funding for Pneumococcal, Rotavirus Vaccines

A child receives a pneumococcal vaccine in Sierra Leone. Photo by: Doune Porter / GAVI Alliance / CC BY-NC-ND

Thirty-seven developing countries — 24 of them in Africa — will be receiving funding for vaccines that will protect against the top two causes of deaths among children, thanks to a public-private global health partnership.

The Global Alliance for Vaccines and Immunization announced it has approved funding for 16 developing countries to introduce rotavirus vaccines and 18 countries to introduce pneumococcal vaccines. 

Rotavirus is the leading cause of severe diarrhea in children under 5 years. More than half a million children worldwide succumb to severe diarrhea each year — 50 percent of them in Africa.

On the other hand, pneumococcal disease causes pneumonia, meningitis and sepsis, which take the lives of more than half a million children worldwide annually — the majority of them in Africa and Asia.

Since its launch in 2000, more than 250 million children have reportedly benefited from new and underused vaccines through GAVI. By 2015, GAVI and its partners plan to immunize more than 90 million children against pneumococcal disease and 50 million children against rotavirus in at least 40 countries.

Read more: 

Read more development aid news online, and subscribe to The Development Newswire to receive top international development headlines from the world’s leading donors, news sources and opinion leaders — emailed to you FREE every business day.

About the author

  • Che de los Reyes

    As a senior staff writer, Che focuses on international development breaking news coverage as well as interviews and features. Prior to joining Devex, Che handled communications for local and international development NGOs and government institutions in the Philippines.